Organon (OGN) EBT Margin (2020 - 2026)

Organon (OGN) posted quarterly EBT Margin of 14.59% for Q1 2026, up 791.0% year-over-year from 1.64% in Q1 2025, and up 248.55% on a QoQ basis from 9.82% in Q4 2025.

Organon (OGN) EBT Margin (2020 - 2026) Analysis & Trends

Organon (OGN) has reported EBT Margin for 7 consecutive years, with 14.59% the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBT Margin rose 791.0% year-over-year to 14.59%; the TTM figure through Mar 2026 stood at 8.71% (down 196.0% YoY), while the FY2025 annual figure was 6.84%, down 577.0% from the prior year.
  • EBT Margin came in at 14.59% for Q1 2026 at Organon, up from 9.82% in the prior quarter.
  • The five-year high for EBT Margin was 37.85% in Q4 2022, with the low at 9.82% in Q4 2025.
  • Average EBT Margin over 5 years is 13.92%, with a median of 14.59% recorded in 2026.
  • Across the five-year window, EBT Margin jumped 2312 bps in 2022 and plunged 3134 bps in 2023, its largest moves.
  • Year by year, EBT Margin stood at 37.85% in 2022, then plunged by 83 bps to 6.51% in 2023, then gained by 25 bps to 8.1% in 2024, then sank by 221 bps to 9.82% in 2025, then jumped by 249 bps to 14.59% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods registered 14.59%, 9.82%, and 15.17% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 44.70%
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 24.89%
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 6.93%
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 27.21%
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -21.49%
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 24.18%
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 37.07%
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 135.53%
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 14.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 14.59%
Dec 31, 2025 -9.82%
Sep 30, 2025 15.17%
Jun 30, 2025 14.37%
Mar 31, 2025 6.68%
Dec 31, 2024 8.10%
Sep 30, 2024 13.08%
Jun 30, 2024 14.62%
Mar 31, 2024 14.55%
Dec 31, 2023 6.51%
Sep 30, 2023 5.27%
Jun 30, 2023 15.80%
Mar 31, 2023 15.28%
Dec 31, 2022 37.85%
Sep 30, 2022 18.35%
Jun 30, 2022 18.11%
Mar 31, 2022 28.21%
Dec 31, 2021 14.72%
Sep 30, 2021 24.31%
Jun 30, 2021 27.40%